ArticleDrug metabolism and disposition: the biological fate of chemicals2015

Hepatoselective Nitric Oxide (NO) Donors, V-PYRRO/NO and V-PROLI/NO, in Nonalcoholic Fatty Liver Disease: A Comparison of Antisteatotic Effects with the Biotransformation and Pharmacokinetics.

Kamil Kus et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.